Global Celiac Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 157013
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 138
  • list Pharmaceuticals and Healthcare

Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease. 

Scope of the Report:

This report focuses on the Celiac Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region. 

The worldwide market for Celiac Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

ADMA Biologics

Amgen

Anthera Pharmaceuticals

Bayer

Biogen

BioLineRx

Biotest

Bristol-Myers Squibb

Celgene

Celimmune

F Hoffmann-La Roche

ImmunogenX

Immunomedics

ImmusanT

Innovate Biopharmaceuticals

Johnson & Johnson

Kedrion Biopharma

LFB Group

Merck

Novartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

First Line Of Treatment

Second Line Of Treatment

Market Segment by Applications, can be divided into

Men

Women

Children

There are 15 Chapters to deeply display the global Celiac Drugs market.

Chapter 1, to describe Celiac Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Celiac Drugs, with sales, revenue, and price of Celiac Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Celiac Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Celiac Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Celiac Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Celiac Drugs Introduction

1.2 Market Analysis by Type

1.2.1 First Line Of Treatment

1.2.2 Second Line Of Treatment

1.3 Market Analysis by Applications

1.3.1 Men

1.3.2 Women

1.3.3 Children

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 ADMA Biologics

2.1.1 Business Overview

2.1.2 Celiac Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 ADMA Biologics Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen

2.2.1 Business Overview

2.2.2 Celiac Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Anthera Pharmaceuticals

2.3.1 Business Overview

2.3.2 Celiac Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bayer

2.4.1 Business Overview

2.4.2 Celiac Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bayer Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Biogen

2.5.1 Business Overview

2.5.2 Celiac Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Biogen Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 BioLineRx

2.6.1 Business Overview

2.6.2 Celiac Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 BioLineRx Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Biotest

2.7.1 Business Overview

2.7.2 Celiac Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Biotest Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Bristol-Myers Squibb

2.8.1 Business Overview

2.8.2 Celiac Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Celgene

2.9.1 Business Overview

2.9.2 Celiac Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Celgene Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Celimmune

2.10.1 Business Overview

2.10.2 Celiac Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Celimmune Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 F Hoffmann-La Roche

2.11.1 Business Overview

2.11.2 Celiac Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 ImmunogenX

2.12.1 Business Overview

2.12.2 Celiac Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 ImmunogenX Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Immunomedics

2.13.1 Business Overview

2.13.2 Celiac Drugs Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Immunomedics Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 ImmusanT

2.14.1 Business Overview

2.14.2 Celiac Drugs Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 ImmusanT Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Innovate Biopharmaceuticals

2.15.1 Business Overview

2.15.2 Celiac Drugs Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Johnson & Johnson

2.16.1 Business Overview

2.16.2 Celiac Drugs Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Johnson & Johnson Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17 Kedrion Biopharma

2.17.1 Business Overview

2.17.2 Celiac Drugs Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Kedrion Biopharma Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.18 LFB Group

2.18.1 Business Overview

2.18.2 Celiac Drugs Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 LFB Group Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.19 Merck

2.19.1 Business Overview

2.19.2 Celiac Drugs Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Merck Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.20 Novartis

2.20.1 Business Overview

2.20.2 Celiac Drugs Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Novartis Celiac Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Celiac Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Celiac Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Celiac Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Celiac Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Celiac Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Celiac Drugs Market Analysis by Regions

4.1 Global Celiac Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Celiac Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Celiac Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Celiac Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Celiac Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Celiac Drugs Sales and Growth Rate (2013-2018)

4.5 South America Celiac Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Celiac Drugs Sales and Growth Rate (2013-2018)

5 North America Celiac Drugs by Countries

5.1 North America Celiac Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Celiac Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Celiac Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Celiac Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Celiac Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Celiac Drugs Sales and Growth Rate (2013-2018)

6 Europe Celiac Drugs by Countries

6.1 Europe Celiac Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Celiac Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Celiac Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Celiac Drugs Sales and Growth Rate (2013-2018)

6.3 UK Celiac Drugs Sales and Growth Rate (2013-2018)

6.4 France Celiac Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Celiac Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Celiac Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Celiac Drugs by Countries

7.1 Asia-Pacific Celiac Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Celiac Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Celiac Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Celiac Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Celiac Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Celiac Drugs Sales and Growth Rate (2013-2018)

7.5 India Celiac Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Celiac Drugs Sales and Growth Rate (2013-2018)

8 South America Celiac Drugs by Countries

8.1 South America Celiac Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Celiac Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Celiac Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Celiac Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Celiac Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Celiac Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Celiac Drugs by Countries

9.1 Middle East and Africa Celiac Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Celiac Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Celiac Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Celiac Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Celiac Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Celiac Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Celiac Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Celiac Drugs Sales and Growth Rate (2013-2018)

10 Global Celiac Drugs Market Segment by Type

10.1 Global Celiac Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Celiac Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Celiac Drugs Revenue and Market Share by Type (2013-2018)

10.2 First Line Of Treatment Sales Growth and Price

10.2.1 Global First Line Of Treatment Sales Growth (2013-2018)

10.2.2 Global First Line Of Treatment Price (2013-2018)

10.3 Second Line Of Treatment Sales Growth and Price

10.3.1 Global Second Line Of Treatment Sales Growth (2013-2018)

10.3.2 Global Second Line Of Treatment Price (2013-2018)

11 Global Celiac Drugs Market Segment by Application

11.1 Global Celiac Drugs Sales Market Share by Application (2013-2018)

11.2 Men Sales Growth (2013-2018)

11.3 Women Sales Growth (2013-2018)

11.4 Children Sales Growth (2013-2018)

12 Celiac Drugs Market Forecast (2018-2023)

12.1 Global Celiac Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Celiac Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Celiac Drugs Market Forecast (2018-2023)

12.2.2 Europe Celiac Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Celiac Drugs Market Forecast (2018-2023)

12.2.4 South America Celiac Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Celiac Drugs Market Forecast (2018-2023)

12.3 Celiac Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Celiac Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Celiac Drugs Market Share Forecast by Type (2018-2023)

12.4 Celiac Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Celiac Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Celiac Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Celiac Drugs Picture

Table Product Specifications of Celiac Drugs

Figure Global Sales Market Share of Celiac Drugs by Types in 2017

Table Celiac Drugs T

Please fill the form below, to recieve the report sample


+1